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Abstract
The cancer stem cell (CSC) model posits the presence of a small number of CSCs in the heterogeneous cancer cell
population that are ultimately responsible for tumor initiation, as well as cancer recurrence and metastasis. CSCs have been
isolated from a variety of human cancers and are able to generate a hierarchical and heterogeneous cancer cell population.
CSCs are also resistant to conventional chemo- and radio-therapies. Here we report that ionizing radiation can induce stem
cell-like properties in heterogeneous cancer cells. Exposure of non-stem cancer cells to ionizing radiation enhanced
spherogenesis, and this was accompanied by upregulation of the pluripotency genes Sox2 and Oct3/4. Knockdown of Sox2
or Oct3/4 inhibited radiation–induced spherogenesis and increased cellular sensitivity to radiation. These data demonstrate
that ionizing radiation can activate stemness pathways in heterogeneous cancer cells, resulting in the enrichment of a CSC
subpopulation with higher resistance to radiotherapy.
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Introduction
Cancer stem cells (CSCs), a subpopulation of malignant cells in
the heterogeneous cancer cell population, are considered to be
responsible for cancer recurrence, metastasis and drug resistance.
CSCs have been isolated from a variety of human malignancies
including leukemia [1,2], breast cancer [3,4], brain tumor [5],
hepatocellular carcinoma [6], pancreatic cancer [7] and colorectal
cancer [8,9]. CSCs have the ability to self-renew and to
differentiate into the multitude of cells that comprise the bulk of
the tumor mass [10,11]. CSCs also express high levels of drug
resistance transporter proteins (e.g. ABC) [12,13,14], DNA repair
enzymes [15,16] and anti-apoptotic proteins [17,18,19], which
renders them highly resistant to conventional cancer therapies
including chemotherapy and radiation. For example, studies
published by Bao et al [20] have demonstrated that ionizing
radiation can enrich CD133+ glioma cancer stem cells in vitro and
in vivo. Moreover, these authors showed that this enrichment effect
was mediated by preferential activation of the DNA damage
checkpoint in CD133+ glioma cancer stem cells compared to
CD133- non-stem glioma cells. The CSC model, therefore, calls
for the design of therapeutics that target CSCs to improve cancer
treatment [21,22].
Although there is increasing evidence to support the CSC
hypothesis, the exact origin of these cells remains controversial.
One possibility is that CSCs result from oncogenic transformation
of normal tissue stem cells [23]. In this scenario, mutations in the
regulatory mechanisms controlling stem cell self-renewal are
thought to promote the formation CSCs [24,25], which then
generate a hierarchical and heterogeneous cancer cells, suggesting
that the originating cancer cell has the capacity to generate
multiple cell types (i.e. multidifferentiative plasticity), a hallmark of
stem-like cells [26,27,28]. Alternatively, CSCs may be derived
from non-stem cancer cells that have acquired stemness properties
[22,29]. In keeping with this, studies published by Quintana et al,
and Roesch et al [30,31] have shown that a CSC phenotype can
be acquired by tumor cells previously negative for specific CSC
markers.
In this study, our data suggest irradiation of cancer cells as
a novel potential origin of cancer stemness. Exposure of
heterogeneous cancer cells to ionizing gamma radiation enhanced
spherogenesis under stem cell culture conditions. Surprisingly,
irradiation of CSC-depleted heterogeneous cancer cell populations
induced the emergence of sphere-forming cells. At the molecular
level, analysis of the pluripotency gene expression following
gamma irradiation showed up-regulation of Sox2 and Oct3/4
mRNA and protein. In contrast, knockdown of Sox2 or Oct3/4
markedly reduced surviving colonies following radiation treat-
ment, and also significantly inhibited radiation–induced spher-
ogenesis. These data demonstrate that radiation can activate
stemness pathways in heterogeneous cancer cells, suggesting
a novel mechanism of resistance of cancer cells to radiotherapy.
They also imply that targeting of CSCs may improve the efficacy
of radiotherapy.
Results
Gamma Radiation Increases Spherogenesis by Cancer
Cells
We first examined the effect of ionizing radiation on the ability
of hepatocellular carcinoma cells, for which a CSC component has
been previously described [6,32], to grow as spheres under stem
cell media (SCM) culture conditions. Single cell suspensions of
HepG2 cells and Huh7 cells were exposed to 0–10 Gy of gamma
radiation (for LD50 see Figure S1) and then seeded at clonal
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Sphere formation was evaluated after 7 days and 14 days of
culture. Both cell lines were able to form spheres (Figures 1c, 1d).
As shown in Figures 1a and 1b, a 40–50% increase in the number
of spheres was observed for HepG2 cells on day 7 and day 14, and
for Huh7 cells on day 14 after treatment with 2 Gy or 4 Gy of
gamma radiation. These findings show that ionizing gamma
radiation can significantly increase the in vitro spherogenesis of
HepG2 and Huh7 cells.
Gamma Radiation Induces Spherogenesis in HepG2 and
Huh7 Non-side Population Cells
Side population flow cytometry (defined by the ability to
exclude the DNA-binding dye Hoechst 33342) [33,34] has been
used to enrich CSC and non-CSC from various cancer cell lines,
as well as cultures derived from primary tumors [26,35,36]. This
approach has shown that HepG2 and Huh7 CSCs represent ,1–
2% of the bulk tumor cells [6,32]. Given that the ability to form
spheres in vitro under non-adherent culture conditions is consid-
ered a property of CSCs [32,37] our data strongly indicate that
Figure 1. Ionizing radiation increases spherogenesis in HCC cells. A and B HepG2 cells (a) and Huh7 cells (b), were exposed to increasing
doses of gamma radiation, and then seeded in stem cell media onto 96-well ultra low attachment plates at 500 cells/well. The sphere numbers were
counted after 7 days (top) and 14 days (bottom) of culture, and relative numbers were reported on the graphs. Lower radiation doses of 2 and 4 Gy
induced a significant increase in sphere formation in both cell lines compared to untreated samples. Results are presented as mean6SEM of four
independent experiments. *p,0.05, **p,0.01 versus untreated control cells. C and D Representative images of HepG2 (c) and Huh7 (d) spheres
formed after 14 days of culture in stem cell media. The images were captured using a digital camera (AmScope, iScope Corp., Chino, CA), mounted on
a Zeiss Axiovert 25 inverted microscope. Magnification: 100x.
doi:10.1371/journal.pone.0043628.g001
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increased in the number of CSCs in both cell lines.
To investigate whether the increased spherogenesis observed
following exposure to gamma radiation might originate within the
heterogeneous non-stem cancer cell population, we used side
population flow cytometry to identify and isolate non-CSC from
HepG2 and Huh7 cells. A typical non-side population sorting
experiment is illustrated in Figure 2a. Cells sensitive to the efflux
pump inhibitor verapamil (R3 gate) show low Hoechst staining
intensity and were identified as the side population (SP)
component of the tumor (i.e. CSC-enriched). Verapamil-insensi-
tive cells with high Hoechst staining intensity (R4 gate) were
isolated as non-side population (non-SP) cells. To exclude the
possibility of non-specific effects on sphere formation resulting
from the FACS sorting procedure, HepG2 and Huh7 cells were
also mock-sorted based on propidium iodide (PI) staining.
Following cell sorting in SCM, non-SP (i.e. CSC depleted) cells
and control cells (unsorted bulk or PI-sorted HepG2 and Huh7)
were irradiated with 0, 2 or 4 Gy of gamma radiation in SCM.
Irradiated bulk, irradiated non-SP cells and irradiated PI-sorted
cells were then seeded onto ultra low attachment plates and sphere
formation was evaluated after 7 and 14 days of culture.
As shown in Figure 2b and Figure 2c, no significant difference in
sphere formation was observed after 7 days of culture in SCM for
unsorted, non-SP, or PI-sorted HepG2 or Huh7 cells subjected to
2 or 4 Gy of gamma radiation. In contrast, unsorted HepG2 cells
exposed to 2Gy of radiation and unsorted Huh7 cells exposed to 2
or 4 Gy of radiation had significantly increased sphere formation
after 14 days of culture in SCM (Figure 2b, 2c). Moreover, PI-
sorted control cells from both cell lines showed similar sphere-
forming ability to unsorted bulk HepG2 or Huh7 cells after
14 days of culture in SCM. Specifically, PI-sorted Huh7 cells
subjected to 2 Gy of gamma radiation showed significantly
increased sphere formation after 14 days of culture in SCM
(p,0.05). PI-sorted HepG2 cells exposed to 2 or 4 Gy of radiation
also displayed markedly elevated sphere formation after 14 days of
culture in SCM. These differences, however, did not reach
statistical significance. Surprisingly, exposure to gamma radiation
markedly induced spherogenesis in the non-SP fractions from
HepG2 and Huh7 cells after 14 days of culture in SCM. For
HepG2 cells, treatment of the non-SP fraction with 2 Gy of
gamma radiation induced a 150% increase in sphere formation
compared to untreated non-SP cells (p,0.001). Similarly,
treatment of Huh7 non-SP cells with 4 Gy of gamma radiation
induced an 80% increase in sphere formation (p,0.01). Taken
together, these data demonstrate that low dose gamma radiation
can promote the formation of CSCs within the heterogeneous
non-stem cancer cell population.
Stemness Gene Expression is Increased in HepG2 and
Huh7 Cells Following Gamma Radiation Treatment
To examine if the increased spherogenesis induced by gamma
radiation may be due to elevated stemness gene expression,
HepG2 cells and Huh7 cells were exposed various doses of gamma
radiation, and the level of Oct3/4 and Sox2 mRNA was evaluated
by real-time PCR. As shown in Figure 3a and 3c, a significant
increase in Oct3/4 mRNA and protein was detected in HepG2
cells 6 hours after exposure to 2 or 4 Gy of gamma radiation.
Increased Oct4 protein levels were also observed in Huh7 cells
6 hours after exposure to 4 Gy of radiation (Figure 3d). Radiation–
induced increases in the level of Huh7 cell Oct3/4 mRNA,
however, did not reach statistical significance (Figure 3b).
Consistent with our findings regarding Oct3/4 expression, we
found that Sox2 mRNA and protein levels were also significantly
increased in Huh7 cells 3 and 6 hours after exposure to 4 Gy of
radiation (Figure 3f, 3h). However, no increase in Sox2 mRNA
and protein levels was detected in HepG2 cells following radiation
treatment (Figure 3e, 3g). These results suggest that gamma
radiation can induce the reprogramming of differentiated cancer
cells to a more stem-like phenotype by inducing stemness gene
expression.
Oct3/4 and Sox2 Knockdown Sensitizes HepG2 and Huh7
Hepatocellular Cancer Cells to Gamma Radiation
Since Sox2 and Oct3/4 upregulation correlates with increased
stemness (spherogenesis) in HepG2 and Huh7 cells following
exposure to gamma radiation, we next examined whether these
factors could affect the ability of HepG2 or Huh7 cells to resist
radiation treatment. For these experiments, Sox2 or Oct4 gene
expression was silenced in Huh7 and HepG2 cells using
asymmetric interfering RNA (aiRNA). aiRNA were chosen,
instead of siRNA, due to their superior specificity [38]. Knock-
down efficiency was evaluated by Western blot 48 h after aiRNA
transfection. aiRNA targeting Sox2 or Oct4 efficiently reduced the
expression of both proteins (Figure 4a and 4b). This is consistent
with previous studies using embryonic stem cells that demonstrate
Oct4 and Sox2 are linked to the same regulatory pathway, which
includes auto-regulatory loops and reciprocal auto-transcription
regulation [39,40]. Single gene knockdown within the Sox2-Oct4
regulatory circuit would, therefore, be expected to reduce the
expression level of both proteins.
To assess the effect of Sox2 or Oct4 knockdown on cell viability
following radiation treatment, Huh7 and HepG2 cells were
transfected with aiRNA targeting Sox2, Oct4 or GFP. After
24 h, the cells were divided and exposed to 0, 2, 4, 6, 8 or 10 Gy of
gamma radiation. Single cell suspensions were then seeded in
complete DMEM in standard 6-well plates to allow the cells to
attach and form colonies. After 7 days of culture in complete
DMEM, the colonies formed under each treatment were stained
and counted. As shown in Figure 4c and 4d, silencing of Sox2 or
Oct4 gene expression in HepG2 and Huh7 cells resulted in
a significant increase in sensitivity to gamma radiation (decreased
LD50 value; see Table 1) when compared to cells transfected with
an aiRNA directed against GFP, or non-transfected cells. These
data suggest that downregulation of stemness genes can sensitize
hepatocellular carcinoma cells to gamma radiation treatment.
Oct3/4 and Sox2 Knockdown in HepG2 or Huh7 Cells
Inhibits Radiation–induced Sphere Formation
Since knockdown of Sox2 or Oct4 increased the sensitivity of
HepG2 and Huh7 cells to radiation treatment, we next examined
whether the spherogenesis ability of HepG2 and Huh7 cells
following gamma irradiation was associated with the expression of
these factors. To assess the effect of radiation treatment, Huh7 and
HepG2 cells were transfected with aiRNA directed against Sox2,
Oct4 or GFP, harvested after 24 h, and then divided and exposed
to 0, 2 or 4 Gy of gamma radiation. Cells were then seeded at
clonal density onto ultra-low attachment plates in serum-free
SCM. After 7 days of culture, gamma-irradiated cells transfected
with aiRNA directed against GFP showed a similar increase in
sphere formation to the untreated group. Huh7 and HepG2 cells
treated with Sox2 or Oct4 aiRNA and exposed to radiation,
however, formed significantly less spheres than control cells
transfected with GFP aiRNA (Figure 5a and 5b). More
importantly, cells treated with Sox2 or Oct4 aiRNA had
a significantly reduced ability to form spheres following exposure
to 2 or 4 Gy of gamma radiation, compared to non irradiated cells.
Radiation-Induced Cancer Stemness
PLOS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e43628Figure 2. Ionizing radiation increases spherogenesis in the non-Side Population fraction of HCC cells. A HepG2 cells (left panels) and
Huh7 cells (right panels) were stained using Hoechst 33342 with (lower panels) or without (upper panels) Verapamil, and then sorted using a MoFLO2
fluorescence activated cell sorter. The R3 gate identified the Side Population (SP) fraction. Non-Side Population (Non-SP) cells, isolated via the R4 gate,
were collected, rinsed in PBS and resuspended in stem cell media. B and C Unsorted, non-SP and PI-sorted HepG2 (b) and Huh7 (c) cells were
exposed to 0, 2 or 4 Gy of gamma radiation and then seeded onto 96-well ultra low attachment plates at 500 cells/well. Sphere numbers were then
counted after 7 days (top panels) and 14 days (bottom panels) of culture, and relative numbers were reported on the graphs. White bars represent
unsorted tumor cells, black bars represent sorted non-side population (non-SP) cells, and hatched bars represent PI-sorted cells. After 14 days of
culture in SCM, radiation doses of 2 and 4 Gy induced a significant increase in sphere formation in the bulk tumor population and in the non-SP
population of both cell lines compared to untreated samples, while PI-sorted Huh7 cells showed significantly increased sphere formation following 2
Gy of radiation treatment. Results are presented as mean6SEM of five independent experiments (unsorted and non-SP populations) or mean6SEM
of two independent experiments (PI-sorted population). *p,0.05, **p,0.01 versus untreated control cells.
doi:10.1371/journal.pone.0043628.g002
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PLOS ONE | www.plosone.org 5 August 2012 | Volume 7 | Issue 8 | e43628In HepG2 cells, a significant inhibition of sphere formation was
also observed in non-irradiated cells upon silencing of Sox2 or
Oct4. Taken together, these results demonstrate that expression of
Sox2 and Oct3/4 is required for CSC in HepG2 and Huh7 cells,
and that upregulation of these factors in non-CSCs may be
sufficient to induce the acquisition of a CSC phenotype, thereby
imparting a higher radiation resistance to the bulk tumor cell
population.
Discussion
Cancer stem cells (CSCs) are thought to represent a small sub-
population of cells present in most tumors that, similar to normal
tissue stem cells, possess the ability to self-renew, to divide
Figure 3. Upregulation of stemness genes in HCC cells after radiation treatment. A and B, E and F HepG2 and Huh7 cells were exposed
to 0, 2 or 4 Gy of gamma radiation and total RNA was extracted after 3, 6 or 24 hours. Oct3/4 (a and b) and Sox2 (e and f) mRNA levels in each cell line
were then determined by quantitative Real-Time PCR and normalized to GAPDH mRNA levels in each sample. In HepG2 cells, treatment with 2 and 4
Gy of gamma radiation induced a significant increase of Oct3/4 mRNA levels. Sox2 mRNA levels were also strongly upregulated in Huh7 cells
following low dose gamma radiation treatment. Results are presented as mean6SEM of four independent experiments. *p,0.05, **p,0.01,
***p,0001 versus t0 sample or untreated samples. The dashed line represents a comparison to the control at the same time point. C and D, G and
H HepG2 cells and Huh7 cells, were exposed to 0, 2 or 4 Gy of gamma radiation and Oct4 or Sox2 protein expression was determined by Western blot
analysis after 6 hours (for Oct4; c and d), or after 4 hours (for Sox2; g and h). Oct4 and Sox2 protein levels increased following radiation treatment
consistent with the increases in mRNA levels for each gene.
doi:10.1371/journal.pone.0043628.g003
Figure 4. Silencing of stemness genes increases the sensitivity of hepatocellular carcinoma cells to gamma radiation. A and B HepG2
cells (a) and Huh7 cells (b), were transfected with 100 nM of aiRNA targeting GFP, Sox2 or Oct4, and knockdown efficiency was evaluated by Western
blot after 48 hours. Sox2 and Oct4 belong to the same regulatory circuit; therefore, single gene knockdown leads to reduced expression levels of
both proteins. C and D HepG2 and Huh7 cells transfected with aiRNA targeting GFP, Sox2 or Oct4 were irradiated with 0, 2, 4, 6, 8 or 10 Gy of gamma
radiation and equal numbers of cells were plated onto 6-well plates for colony formation assay. On day 7, colonies were counted and the fraction of
surviving clonogenic cells expressed as a natural log was plotted. Lines are fitted using a first-order polynomial regression and represent the mean of
four independent experiments. *p,0.05, **p,0.01, ***p,0.001 versus GFP-transfected cells.
doi:10.1371/journal.pone.0043628.g004
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differentiation [41,42]. These features of CSCs are fundamentally
responsible for their unique ability to initiate and sustain tumors
[10,42,43]. Moreover, CSCs are also believed to play a key role in
cancer metastasis, cancer recurrence, and cancer drug resistance
[15,20,44,45].
In this study, we demonstrate that cancer cells can be induced,
by gamma radiation, to acquire a stemness state characterized by
increased stemness gene expression and a cancer stem cell-like
phenotype. Side population flow cytometry has shown that CSCs
in HepG2 and Huh7 represent approximately 1–2% of the bulk
tumor cells [6,32]. Given that the ability to form spheres in vitro
under non-adherent culture conditions is specific to CSCs [32,37],
our data suggest that gamma irradiation of HepG2 and Huh7 cells
significantly increased in the number of CSCs in both cell lines.
Recent publications have shown that, unlike bulk tumor cells,
CSCs possess intrinsic resistance to radiation therapy in vitro and
in vivo [20,45,46], and that this property most likely results from
higher expression of free radical-removing enzymes, increased
efficiency in DNA-damage repair, and preferential DNA-damage
checkpoint activation [15,16,20,47]. To further explore the origin
of the increased numbers of CSCs in gamma irradiated HepG2
and Huh7 cells we performed flow cytometry using Hoechst 33342
dye exclusion to isolate side population (SP) cells that are enriched
in CSC, and non-side population (non-SP) cells that are depleted
of CSC. Surprisingly, we observed significantly increased sphere
formation in HepG2 and Huh7 non-SP cells following exposure to
2 or 4 grey of gamma radiation (Figure 2). Moreover, increased
sphere formation was also seen in untreated HepG2 and Huh7
non-SP cells. These findings indicate that non-SP cells (i.e. non-
CSC tumor cells) can acquire CSC-like properties, and are
consistent with the recent concept that tumors are comprised of
a variety of cells at different maturation stages [48,49], with the
ability to convert into a more stem cell-like state [50,51].
Previous studies have reported that radiation-induced enrich-
ment of CSCs is associated with activation of self-renewal signaling
pathways such as Wnt/b-catenin, Notch and Hedgehog
[52,53,54]. Moreover, since CSCs are capable of both asymmetric
and symmetric cell division [55,56] the enrichment effect is
thought to be mediated primarily by CSCs undergoing symmetric
cell division. Our data, however, suggest that an additional
component of this effect may be the acquisition of stemness
characteristics upon radiation treatment by non-stem cancer cells.
This finding is further supported by our observation of increased
Sox2 and Oct3/4 pluripotency gene expression in hepatocellular
carcinoma cells following gamma irradiation (Figure 3).
Along with c-Myc, Klf4 and NANOG, Sox2 and Oct3/4
transcription factors are considered key genes for the production of
murine and human induced pluripotent stem cells [57,58].
Table 1. Mean slope 6 SEM and LD50 value for each
treatment.
CELL LINE SAMPLE SLOPE 6 SEM LD50
HepG2 NT 20.2160.0063 3.24
GFP 20.2260.0072 3.08
SOX 2 20.3160.0081 2.29
OCT 4 20.3060.0115 2.33
Huh7 NT 20.1560.0048 4.68
GFP 20.1660.0053 4.41
SOX 2 20.2160.0101 3.27
OCT 4 20.2060.0098 3.36
Slope values are expressed as the natural log of the colony survival fraction. The
mean of four independent experiments is shown.
doi:10.1371/journal.pone.0043628.t001
Figure 5. Downregulation of Sox2 and Oct3/4 expression inhibits sphere formation induced by radiation treatment. A and B HepG2
cells and Huh7 cells transfected with aiRNA targeting GFP, Sox2 or Oct4 were exposed after 24 hours to 0, 2 or 4 Gy of gamma radiation and then
plated onto 96-well ultra low attachment plates at 500 cells/well in stem cell media. Sphere numbers for each knockdown group and radiation
treatment were recorded on day 7 of culture in stem cell media. Silencing of Sox2 or Oct4 significantly reduced sphere formation in HepG2 and Huh7
cells treated with low doses of gamma radiation compared to non-irradiated cells, or cells transfected with aiRNA against GFP. Results are presented
as mean6SEM of four independent experiments, n=4. *p,0.05, **p,0.01, versus GFP-transfected cells or non-irradiated control cells (0 Gy).
doi:10.1371/journal.pone.0043628.g005
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mental role in ensuring the maintenance of self-renewal, plasticity
and the reprogramming ability in both embryonic stem cells and
CSCs [59,60,61,62]. Increased expression of Sox2 and Oct3/4
following gamma radiation treatment (Figure 3) is, therefore,
consistent with induction of a genetic program in some HepG2
and Huh7 cells that results in increased stemness, and the
acquisition of a stem cell-like phenotype [63,64,65]. Since the
CSC component in both cell lines represents #2% of the total cell
population (Figure 2) [6,32], the observed overexpression of Sox2
and Oct3/4 in HepG2 and Huh7 cells following low dose
irradiation most likely represents changes in the non-CSC
population.
In this study, we found that down regulation of Sox2 and Oct3/
4 in HepG2 or Huh7 cells was associated with lower resistance to
gamma radiation in a clonogenic survival assay which allows for
the survival and proliferation of non-stem cancer cells as well as
CSCs (Figure 4). This finding is in keeping with previous studies
demonstrating that the radioresistance of bulk tumors cells appears
to be related to the CSC component of the tumor population
[20,45,46]. To examine this further, we knocked down Sox2 or
Oct4 expression in HepG2 or Huh7 cells using asymmetric-RNA
technology and examined their ability to grow as sphere cultures.
We found that knockdown of Sox2 or Oct4 expression was
associated with a significant decrease in sphere formation
following gamma radiation treatment (Figure 5). Since this
experiment was performed under stem cell culture conditions,
which are selective for CSC enrichment and survival, our results
should only reflect the effect of Sox2 and Oct3/4 knockdown on
CSCs. Interestingly, Sox2 and Oct3/4 downregulation signifi-
cantly reduced the sphere forming ability in non-irradiated
HepG2 and Huh7 cells, indicating that these factors may also be
required for maintenance of existing CSCs. These findings suggest
that knockdown of Sox2 and Oct3/4 may be a potential approach
for sensitizing hepatocellular carcinomas to radiotherapy since
blockade these factors can prevent the self-renewal of non-CSCs
that have acquired stemness properties, as well as existing CSCs.
Long-term, non-targeted effects, of ionizing radiation such as
genomic instability, adaptive responses and the bystander effect
are considered to have a major role in radiation-induced
carcinogenesis [66,67,68]. Exposure of cells to radiation, especially
low doses, can mediate genomic instability and adaptive responses
that have the potential to induce gene expression, chromosomal
rearrangement, post-translational modifications and epigenetic
changes that initiate carcinogenesis. These changes can also be
induced in other cells that have not been subjected to initial
radiation-damage (by the bystander effect) leading to a more
amplified phenotype. Moreover, they are heritable, non-clonal,
and rely on epigenetic modifications such as dysregulation of DNA
methylation [69,70,71]. Our finding that gamma radiation can
induce spherogenesis in non-stem cancer cells, and that this
process requires the expression of Sox2 and Oct3/4, are consistent
with the activation of a ‘‘stemness program’’ mediated by non-
targeted epigenetic effects in irradiated cells where the reprogram-
ming of gene expression is associated significantly increased radio-
resistance [72].
For the past century, radiation therapy has been used
extensively as a curative or adjuvant cancer treatment, and low
dose radiation as a palliative measure for managing patients with
advanced cancer. However, most human malignancies, including
hepatoma, are refractory to this important therapeutic modality.
In this study, we show that radiation can induce stem cell-like
properties such as sphere formation and stemness gene expression
in non-CSCs, demonstrating that non-stem cancer cells can
acquire a more stem cell-like state with enhanced ability to self-
renew, suggesting a novel mechanism for the radioresistance
commonly observed in human malignancies.
Methods
Cell Culture and Drug Treatment
HepG2 hepatocellular carcinoma cells were purchased from
American Type Culture Collection (HB-8065). Huh7 hepatocel-
lular carcinoma cells were kindly provided by Dr. Raymond
Chung [73,74]. HepG2 and Huh7 human hepatocellular carci-
noma cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma-Aldrich) supplemented with 10% heat-inactivated
fetal bovine serum (FBS; Sigma-Aldrich), 2 mM glutamine,
50 IU/ml penicillin and 50 mg/ml streptomycin in a humidified
atmosphere containing 5% CO2 at 37uC. To assess sphere
formation (spherogenesis) HepG2 and Huh7 cells were cultured in
stem cell media (SCM) comprised of DMEM-F12 media, 16B27
supplement, 200 ng/ml EGF, 10 ng/ml basic FGF, 0.4% BSA,
4 mg/ml insulin, 50 IU/ml penicillin and 50 mg/ml streptomycin
in a humidified atmosphere containing 5% CO2 at 37uC.
Gamma Radiation Treatment
Unsorted HepG2 and Huh7 cells and non-SP sorted population
suspended in SCM were aliquoted into 1.5 ml tubes at a concen-
tration of 1610
6 cells/ml. The tubes were placed on ice and
irradiated with 0 Gy, 2 Gy, 4 Gy, 6 Gy, 8 Gy or 10 Gy of gamma
radiation using a
137Cs irradiator (CIS Diagnostic). The treated
cells were then seeded in SCM for spherogenesis assay (at
0.5610
3/well), or in complete DMEM for MTT viability assay (at
1610
3 cells/well) and colony formation assay (at 3610
3 cells/
well).
Hoechst 33342 Staining and Side Population Flow
Cytometry
Side Population flow cytometry was performed according to the
method of Goodell et al. [75] with modifications to improve the
staining for hepatic cell lines. Briefly, HepG2 or Huh7 cultures
were trypsinized, and the detached cells were collected by
centrifugation at 500 r.p.m. for 5 minutes. The pelleted cells were
resuspended at a concentration of 10
6 cells/ml in pre-warmed
DMEM, supplemented with 2% FBS and 10 mM HEPES,
containing 5 mg/ml Hoechst 33342 (Sigma-Aldrich) with or
without 50 mM verapamil (Sigma-Aldrich). The cells were then
incubated at 37uC in a water bath for 90 minutes with gentle
mixing every 15 minutes. At the end of the incubation period, the
cells were centrifuged at 500 r.p.m. for 5 minutes at 4uC, and
resuspended at a final concentration of 2610
7 cells/ml in ice-cold
Hank’s Buffered Salt Solution supplemented with 0.2% FBS,
10 mM HEPES, 40 mm mesh-filtered and stained with 2 mg/ml
propidium iodide. The samples were kept on ice until they were
separated using a MoFlo high-speed FACS machine (DakoCyto-
mation) into fractions containing Side Population (SP) cells and
non-Side Population (non-SP) cells [6,32,33,34]. Hoechst 33342
was excited using a UV laser at 350 nm and its fluorescence was
detected using a 450 nm Hoechst blue filter and a 670 nm
Hoechst red filter. Propidium iodide fluorescence was measured
using a 650 nm filter. Non-SP and unsorted cells were then
transferred into SCM for gamma radiation treatment and analysis
of sphere formation. For PI-sorting of bulk cells, HepG2 and
Huh7 cells were resuspended at a concentration of 10
6 cells/ml in
pre-warmed DMEM, supplemented with 2% FBS and 10 mM
HEPES, then processed as described above. Cells were sorted
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gamma radiation treatment and analysis of sphere formation.
In vitro Spherogenesis Assay
Non-irradiated and gamma-irradiated unsorted HepG2 and
Huh7 cells and non-SP sorted populations were washed three
times with SCM to remove all traces of FBS. HepG2 and Huh7
cell suspensions (100 ml) were then plated onto ultra-low attach-
ment 96 well plates (Fisher Scientific) at density of 5 or 10 cells/ml
(i.e. 0.5610
3 cells/well or 1610
3 cells/well respectively) in SCM.
Sphere growth was monitored for 5–14 days, and the number of
spheres was counted on day 7 and day 14. To keep volume of
media in the well constant, ,25 ml of SCM was added every 4–
5 days. At the end of the experiment (day 14) 10 ml of trypan blue
dye solution (Sigma-Aldrich) was added to each well to detect dead
cells. An average of 6 wells were seeded for each radiation dose.
Quantitative Real-time PCR
Total RNA was prepared from HepG2 and Huh7 cells 0, 3, 6
and 24 hours after gamma radiation treatment using TRIzol
reagent (Invitrogen) according to the manufacturer’s instructions.
RNA (5 mg) was then treated with DNAse and reverse transcribed
into cDNA using a High Capacity cDNA-Reverse Transcription
Kit (Applied Biosystems). TaqMan quantitative real-time PCR for
Sox2 and Oct3/4 mRNA was then performed using an ABI 7700
Sequence Detector System (Applied Biosystems) and normalized
to GAPDH levels in each sample. TaqMan primers/probes for
Sox2, Oct3/4 and GAPDH were purchased commercially
(Applied Biosystems). Relative changes in the amount of mRNA
were calculated based on the DDCT method.
Western Blotting
HepG2 and Huh7 cell samples for Western blot analysis of Sox2
and Oct4 protein levels were collected 6 and 24 hours after
gamma radiation treatment. Briefly, the cells were lysed in a buffer
solution of 2 mM HEPES (pH 6.5) and 2.0% SDS by 3 cycles of
boiling for 5 minutes flowed by incubation on ice for 2 minutes.
Proteins were then precipitated at 220uC using 60% acetone for
at least 2 hours, and centrifuged at 12000 r.p.m. for 20 minutes at
4uC. The protein pellets were the air-dried and resuspended in 80
to 150 ml of lysis buffer, depending on cell pellet size, left at 50uC
for 30 min. and then the protein concentration was quantified by
using a Micro BCA Protein Assay (Fisher Scientific). Samples
containing 8 mg total protein were then separated by 10% SDS-
PAGE and transferred to nitrocellulose membranes. The mem-
branes were blocked at room temperature for 1 hour by
incubation in TBS containing 0.1% Tween (TBST) containing
5% (w/v) low fat milk. After blocking, the membranes were
washed in twice TBST, and then incubated with a rabbit
polyclonal human Oct4 antibody (1:1500; Abcam), a rabbit
polyclonal human Sox2 antibody (1:800; Santa Cruz Biotechnol-
ogy) or a rabbit polyclonal human a-tubulin antibody (1:2000; Cell
Signaling Technology) in blocking buffer for 1 hour. After washing
three times in TBST, the membranes were incubated with an
HRP-conjugated anti-rabbit IgG antibody (1:3000; BioRad) in
blocking buffer for 1 hour. After washing three times in TBST,
primary antibody binding was visualized by enhanced chemilu-
minescence and x-ray film. Protein band density was quantified
using Image J software.
Stemness Gene Knockdown
Two aiRNAs [38] targeting Sox2 or Oct4, and one aiRNA
targeting GFP were generated using the following sequences:
SOX2 (1): SS, 59-AAGAGGAGAGUAAGA; AS, 59-AAUU-
CUUACUCUCCUCUUUUG
SOX2(2): SS, 59-AAGAAAACUUUUAUG; AS, 59-AAU-
CAUAAAAGUUUUCUUGUC
OCT4(1): SS, 59-UGAUGCUCUUGAUUU; AS, 59-
AAAAAAUCAAGAGCAUCAUUG
OCT4(2): SS, 59-GCAUUCAAACUGAGG; AS, 59-AAAC-
CUCAGUUUGAAUGCAUG
GFP: SS 59-UAUGUACAGGAACGC; AS 59-AAUGC-
GUUCCUGUACAUAACC
aiRNAs (100 nM) were transfected into HepG2 and Huh7 cells
using Dharmafect Reagent 4 (Dharmacon, Lafayette, Colorado).
After 24 hours, samples were harvested, washed twice in SCM and
irradiated with either 0, 2 or 4 Gy. Cell suspensions (100 ml) were
then plated into ultra-low attachment 96 well plates (Fisher
Scientific) at 0.5610
3 cells/well in triplicate, and spheres were
counted on Day 7, after addition of 10 ml of trypan blue dye
solution. Western Blot assays were performed 48 h after aiRNA
transfection to determine knock down efficiency as described
above.
Radiation Survival
HepG2 and Huh7 cell viability after irradiation was determined
by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay. LD50 was estimated by non-linear regression first
order polynomial equation generated with GraphPad Prism
version 4.00, GraphPad Software, San Diego, California, USA.
MTT Assay
Briefly, HepG2 or Huh7 cells, irradiated by 0 Gy, 2 Gy, 4 Gy, 6
Gy, 8 Gy and 10 Gy, were seeded in quadruplicate onto 96 well
plates in complete DMEM at a concentration of 1610
3 cells/well
and then incubated at 37uC, 5% CO2 for 6 days. 10 ml of 5 mg/
ml MTT solution (Sigma-Aldrich) were added to each well, in
a 1:10 dilution to media, followed by 5 minutes plate mixing.
Plates were then placed in the dark at 37uC for 4 hours. After
incubation, media with MTT was discarded from plates and they
were dried on a paper towel for few minutes. Formazan crystals
formed at bottom of the wells were solubilized in 100 ml DMSO
and the plates were mixed for 5 minutes before being scanned in
a multiwell spectrophotometer (VersaMax microplate reader,
Molecular Devices, Sunnyvale, California) at wavelength of
560 nm. Background optical density was read at 670 nm and
subtracted from formazan O.D. All sets of experiments were
performed in triplicate for each cell line.
Colony Formation Assay
For radioresistance evaluation, HepG2 and Huh7 cells were
transfected with aiRNA (100 nM) targeting GFP, Sox2 or Oct4, as
described above. Cells were collected 24 hours after aiRNA
treatment and each sample was divided into 6 aliquots for
treatment with 0 Gy, 2 Gy, 4 Gy, 6 Gy, 8 Gy and 10 Gy of gamma
irradiation. For each dose, identical numbers of cells were seeded
in triplicate onto 6-well plates in complete DMEM. After 7 days,
media was removed from wells, colony were washed with PBS
twice, before being stained with Hema 3 System (Fisher
Healthcare). Wells were then washed with distilled water, the
plates were scanned, and images of each well were analyzed using
DotCount software v1.1 (Dr. Martin Reuter, http://reuter.mit.
edu/software/dotcount/) and number of colonies consisting of at
least 50 cells was recorded. A total of 4 independent experiments
were performed. LD50 was estimated by non-linear regression first
order polynomial equation generated with GraphPad Prism
version 4.00, GraphPad Software, San Diego, California, USA.
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All results are presented as mean6SEM. Statistical analysis was
performed using unpaired t-test (Figure 1, panels a and b; Figure 4,
panels c and d) or one-way ANOVA followed by post hoc Dunnett’s
test (Figure 2, panels b and c). In Figure 3, panels a to d, and in
Figure 5, panels a and b, statistical significance was assessed by
one-way ANOVA followed by post hoc Dunnett’s test for intergroup
comparisons. P,0.05 was considered significant. All statistical
analyses were performed using GraphPad Prism (version 4.00)
software.
Supporting Information
Figure S1 HepG2 and Huh7 cell radio-sensitivity in-
creases with gamma radiation dose. HepG2 cells and Huh7
cells were exposed to increasing doses of gamma radiation and
then plated onto 96-well plates for viability evaluation by MTT
assay (A and B). MTT assay was performed after 6 days of culture
and an LD50=4.33 or LD50=4.48 Gy were observed for HepG2
and Huh7 cells, respectively. The viable fraction of cells at each
radiation dose, expressed as natural log is plotted on the graphs.
Lines were fitted using a first-order polynomial regression. Results
are presented as the mean6SEM of three independent experi-
ments where each radiation treatment group was seeded in
triplicate.
(TIF)
Acknowledgments
The authors thank Claudia Stenstrom of the Radiation Safety Department
at Beth Israel Medical Center for helping with the radiation treatments.
Author Contributions
Conceived and designed the experiments: LG AK CL. Performed the
experiments: LG XH. Analyzed the data: LG AK CL. Contributed
reagents/materials/analysis tools: DL CL. Wrote the paper: LG AK CL.
Helpful discussion: XH DL. Critical revision of the manuscript: AK CL.
References
1. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as
a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730–
737.
2. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell
initiating human acute myeloid leukaemia after transplantation into SCID mice.
Nature 367: 645–648.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003)
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad
Sci U S A 100: 3983–3988.
4. Liu S, Dontu G, Wicha MS (2005) Mammary stem cells, self-renewal pathways,
and carcinogenesis. Breast Cancer Res 7: 86–95.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004)
Identification of human brain tumour initiating cells. Nature 432: 396–401.
6. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, et al. (2006) Side
population purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology 44: 240–251.
7. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. (2007) Identification of
pancreatic cancer stem cells. Cancer Res 67: 1030–1037.
8. O’Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell
capable of initiating tumour growth in immunodeficient mice. Nature 445: 106–
110.
9. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007)
Identification and expansion of human colon-cancer-initiating cells. Nature 445:
111–115.
10. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and
cancer stem cells. Nature 414: 105–111.
11. Woodruff MF (1983) Cellular heterogeneity in tumours. Br J Cancer 47: 589–
594.
12. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, et al. (2010) CD13 is
a therapeutic target in human liver cancer stem cells. J Clin Invest 120: 3326–
3339.
13. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of
ATP-dependent transporters. Nat Rev Cancer 2: 48–58.
14. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, et al. (1998) A
multidrug resistance transporter from human MCF-7 breast cancer cells. Proc
Natl Acad Sci U S A 95: 15665–15670.
15. Martin LP, Hamilton TC, Schilder RJ (2008) Platinum resistance: the role of
DNA repair pathways. Clin Cancer Res 14: 1291–1295.
16. Zhang M, Atkinson RL, Rosen JM (2010) Selective targeting of radiation-
resistant tumor-initiating cells. Proc Natl Acad Sci U S A 107: 3522–3527.
17. Madjd Z, Mehrjerdi AZ, Sharifi AM, Molanaei S, Shahzadi SZ, et al. (2009)
CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl–2 in
breast tumours. Cancer Immun 9: 4.
18. Zobalova R, McDermott L, Stantic M, Prokopova K, Dong LF, et al. (2008)
CD133-positive cells are resistant to TRAIL due to up-regulation of FLIP.
Biochem Biophys Res Commun 373: 567–571.
19. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, et al. (2006) Analysis of gene
expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
Mol Cancer 5: 67.
20. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells
promote radioresistance by preferential activation of the DNA damage response.
Nature 444: 756–760.
21. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer
stem cells–perspectives on current status and future directions: AACR Workshop
on cancer stem cells. Cancer Res 66: 9339–9344.
22. Blagosklonny MV (2006) Target for cancer therapy: proliferating cells or stem
cells. Leukemia 20: 385–391.
23. Visvader JE (2011) Cells of origin in cancer. Nature 469: 314–322.
24. Gregory CA, Prockop DJ, Spees JL (2005) Non-hematopoietic bone marrow
stem cells: molecular control of expansion and differentiation. Exp Cell Res 306:
330–335.
25. Collins CA, Partridge TA (2005) Self-renewal of the adult skeletal muscle
satellite cell. Cell Cycle 4: 1338–1341.
26. Kondo T, Setoguchi T, Taga T (2004) Persistence of a small subpopulation of
cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101:
781–786.
27. Poste G, Greig R (1982) On the genesis and regulation of cellular heterogeneity
in malignant tumors. Invasion Metastasis 2: 137–176.
28. Sell S, Pierce GB (1994) Maturation arrest of stem cell differentiation is
a common pathway for the cellular origin of teratocarcinomas and epithelial
cancers. Lab Invest 70: 6–22.
29. Blagosklonny MV (2007) Cancer stem cell and cancer stemloids: from biology to
therapy. Cancer Biol Ther 6: 1684–1690.
30. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, et al. (2010)
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that
is reversible and not hierarchically organized. Cancer Cell 18: 510–523.
31. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et
al. (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is
required for continuous tumor growth. Cell 141: 583–594.
32. Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, et al. (2006)
Cancer stem cells in human gastrointestinal cancers. Hum Cell 19: 24–29.
33. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, et al. (2001) The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and
is a molecular determinant of the side-population phenotype. Nat Med 7: 1028–
1034.
34. Robinson SN, Seina SM, Gohr JC, Kuszynski CA, Sharp JG (2005) Evidence for
a qualitative hierarchy within the Hoechst-33342 ‘side population’ (SP) of
murine bone marrow cells. Bone Marrow Transplant 35: 807–818.
35. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A
distinct ‘‘side population’’ of cells with high drug efflux capacity in human tumor
cells. Proc Natl Acad Sci U S A 101: 14228–14233.
36. Chen JS, Pardo FS, Wang-Rodriguez J, Chu TS, Lopez JP, et al. (2006) EGFR
regulates the side population in head and neck squamous cell carcinoma.
Laryngoscope 116: 401–406.
37. Reynolds BA, Rietze RL (2005) Neural stem cells and neurospheres–re-
evaluating the relationship. Nat Methods 2: 333–336.
38. Xiang S, Fruehauf J, Li CJ (2006) Short hairpin RNA-expressing bacteria elicit
RNA interference in mammals. Nat Biotechnol 24: 697–702.
39. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:
947–956.
40. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. (2007)
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse
embryonic stem cells. Nat Cell Biol 9: 625–635.
41. Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:
1253–1261.
42. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours:
accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755–768.
43. Wicha MS (2006) Cancer stem cells and metastasis: lethal seeds. Clin Cancer
Res 12: 5606–5607.
Radiation-Induced Cancer Stemness
PLOS ONE | www.plosone.org 10 August 2012 | Volume 7 | Issue 8 | e4362844. Clarke MF, Fuller M (2006) Stem cells and cancer: two faces of eve. Cell 124:
1111–1115.
45. Baumann M, Krause M, Hill R (2008) Exploring the role of cancer stem cells in
radioresistance. Nat Rev Cancer 8: 545–554.
46. Debeb BG, Xu W, Woodward WA (2009) Radiation resistance of breast cancer
stem cells: understanding the clinical framework. J Mammary Gland Biol
Neoplasia 14: 11–17.
47. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, et al. (2009) Association of
reactive oxygen species levels and radioresistance in cancer stem cells. Nature
458: 780–783.
48. Axelrod R, Axelrod DE, Pienta KJ (2006) Evolution of cooperation among
tumor cells. Proc Natl Acad Sci U S A 103: 13474–13479.
49. Inda MM, Bonavia R, Mukasa A, Narita Y, Sah DW, et al. (2010) Tumor
heterogeneity is an active process maintained by a mutant EGFR-induced
cytokine circuit in glioblastoma. Genes Dev 24: 1731–1745.
50. Bussolati B, Grange C, Sapino A, Camussi G (2009) Endothelial cell
differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med
13: 309–319.
51. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, et al. (2011) Stochastic
state transitions give rise to phenotypic equilibrium in populations of cancer
cells. Cell 146: 633–644.
52. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, et al. (2007)
WNT/beta-catenin mediates radiation resistance of mouse mammary pro-
genitor cells. Proc Natl Acad Sci U S A 104: 618–623.
53. Phillips TM, McBride WH, Pajonk F (2006) The response of CD24(2/low)/
CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777–
1785.
54. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A (2007)
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell
self-renewal, and tumorigenicity. Curr Biol 17: 165–172.
55. Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in
development and cancer. Nature 441: 1068–1074.
56. Boman BM, Wicha MS, Fields JZ, Runquist OA (2007) Symmetric division of
cancer stem cells–a key mechanism in tumor growth that should be targeted in
future therapeutic approaches. Clin Pharmacol Ther 81: 893–898.
57. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–
676.
58. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al.
(2007) Induced pluripotent stem cell lines derived from human somatic cells.
Science 318: 1917–1920.
59. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4
defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet
24: 372–376.
60. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent
cell lineages in early mouse development depend on SOX2 function. Genes Dev
17: 126–140.
61. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR (2007) OCT-4, an embryonic stem
cell marker, is highly expressed in bladder cancer. Int J Cancer 120: 1598–1602.
62. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, et al. (2009)
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation
and loss of tumorigenicity. Stem Cells 27: 40–48.
63. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat
Rev Cancer 3: 401–410.
64. Bissell MJ, Labarge MA (2005) Context, tissue plasticity, and cancer: are tumor
stem cells also regulated by the microenvironment? Cancer Cell 7: 17–23.
65. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, et al.
(2007) Reprogramming metastatic tumour cells with embryonic microenviron-
ments. Nat Rev Cancer 7: 246–255.
66. Little JB (2000) Radiation carcinogenesis. Carcinogenesis 21: 397–404.
67. Smith LE, Nagar S, Kim GJ, Morgan WF (2003) Radiation-induced genomic
instability: radiation quality and dose response. Health Phys 85: 23–29.
68. Mothersill C, Seymour C (2003) Radiation-induced bystander effects, carcino-
genesis and models. Oncogene 22: 7028–7033.
69. Kaup S, Grandjean V, Mukherjee R, Kapoor A, Keyes E, et al. (2006)
Radiation-induced genomic instability is associated with DNA methylation
changes in cultured human keratinocytes. Mutat Res 597: 87–97.
70. Morgan WF, Sowa MB (2005) Effects of ionizing radiation in nonirradiated
cells. Proc Natl Acad Sci U S A 102: 14127–14128.
71. Morgan WF, Sowa MB (2007) Non-targeted bystander effects induced by
ionizing radiation. Mutat Res 616: 159–164.
72. Trosko JE (1998) Hierarchical and cybernetic nature of biologic systems and
their relevance to homeostatic adaptation to low-level exposures to oxidative
stress-inducing agents. Environ Health Perspect 106 Suppl 1: 331–339.
73. Nakabayashi H, Taketa K., Miyano K., Yamane T. and Sato J. (1982) Growth
of Human Hepatoma Cell Lines with Differentiated Functions in Chemically
Defined Medium. Cancer Res 42: 3858–3863.
74. Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, et al. (2006) Hepatitis C
virus core protein blocks interferon signaling by interaction with the STAT1
SH2 domain. J Virol 80: 9226–9235.
75. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC (1996) Isolation and
functional properties of murine hematopoietic stem cells that are replicating in
vivo. J Exp Med 183: 1797–1806.
Radiation-Induced Cancer Stemness
PLOS ONE | www.plosone.org 11 August 2012 | Volume 7 | Issue 8 | e43628